Icecure Historical Income Statement

ICCM Stock

USD 0.71 0.11 18.33%

Historical analysis of Icecure Medical income statement accounts such as Selling General Administrative of 2.4 M or Selling And Marketing Expenses of 4.7 M can show how well Icecure Medical performed in making a profits. Evaluating Icecure Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Icecure Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Icecure Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Icecure Medical is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.

About Icecure Income Statement Analysis

Icecure Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Icecure Medical shareholders. The income statement also shows Icecure investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Icecure Medical Income Statement Chart

At this time, Icecure Medical's Income Tax Expense is very stable compared to the past year. As of the 24th of November 2024, Net Interest Income is likely to grow to about 970.2 K, while Selling General Administrative is likely to drop about 2.4 M.

Selling General Administrative Selling And Marketing Expenses Total Revenue Other Operating Expenses Reconciled Depreciation

Total Revenue

Total revenue comprises all receipts Icecure Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Icecure Medical. It is also known as Icecure Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Icecure Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Icecure Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.At this time, Icecure Medical's Income Tax Expense is very stable compared to the past year. As of the 24th of November 2024, Net Interest Income is likely to grow to about 970.2 K, while Selling General Administrative is likely to drop about 2.4 M.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	11.9M	18.2M	16.9M	17.7M
Cost Of Revenue	1.9M	1.6M	1.9M	1.1M

Total Operating Expenses Cost Of Revenue

Icecure Medical income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Interest Income	Interest Income	Net Income From Continuing Ops	Reconciled Depreciation
Depreciation And Amortization		0.34	0.62	0.95	0.32	0.2	0.8	-0.84	-0.85	0.73	-0.85	0.46	0.82	-0.85	0.28	-0.84	0.17	0.87	0.79	-0.3	-0.01
Interest Expense	0.34		-0.01	0.15	-0.36	-0.41	-0.1	0.02	-0.01	-0.19	0.0	-0.24	-0.09	-0.04	-0.66	-0.04	-0.71	0.04	0.04	0.35	-0.38
Selling General Administrative	0.62	-0.01		0.64	0.75	0.63	0.88	-0.89	-0.89	0.87	-0.89	0.86	0.88	-0.91	0.53	-0.91	0.59	0.56	0.68	-0.51	0.14
Selling And Marketing Expenses	0.95	0.15	0.64		0.41	0.28	0.86	-0.88	-0.89	0.78	-0.88	0.56	0.87	-0.88	0.42	-0.87	0.31	0.91	0.74	-0.44	0.12
Total Revenue	0.32	-0.36	0.75	0.41		0.98	0.74	-0.64	-0.62	0.77	-0.63	0.95	0.71	-0.63	0.75	-0.64	0.77	0.39	0.67	-0.58	0.61
Gross Profit	0.2	-0.41	0.63	0.28	0.98		0.63	-0.51	-0.49	0.68	-0.5	0.87	0.61	-0.5	0.72	-0.51	0.75	0.27	0.63	-0.53	0.67
Other Operating Expenses	0.8	-0.1	0.88	0.86	0.74	0.63		-0.99	-0.98	0.99	-0.98	0.84	1.0	-0.98	0.7	-0.98	0.67	0.81	0.8	-0.66	0.31
Operating Income	-0.84	0.02	-0.89	-0.88	-0.64	-0.51	-0.99		1.0	-0.96	1.0	-0.78	-0.99	1.0	-0.62	1.0	-0.6	-0.82	-0.76	0.62	-0.2
Ebit	-0.85	-0.01	-0.89	-0.89	-0.62	-0.49	-0.98	1.0		-0.96	1.0	-0.77	-0.99	1.0	-0.6	1.0	-0.57	-0.82	-0.75	0.61	-0.18
Research Development	0.73	-0.19	0.87	0.78	0.77	0.68	0.99	-0.96	-0.96		-0.96	0.85	0.98	-0.95	0.78	-0.95	0.75	0.76	0.76	-0.72	0.38
Ebitda	-0.85	0.0	-0.89	-0.88	-0.63	-0.5	-0.98	1.0	1.0	-0.96		-0.77	-0.99	1.0	-0.61	1.0	-0.58	-0.82	-0.75	0.62	-0.18
Cost Of Revenue	0.46	-0.24	0.86	0.56	0.95	0.87	0.84	-0.78	-0.77	0.85	-0.77		0.82	-0.77	0.73	-0.78	0.74	0.55	0.66	-0.61	0.48
Total Operating Expenses	0.82	-0.09	0.88	0.87	0.71	0.61	1.0	-0.99	-0.99	0.98	-0.99	0.82		-0.98	0.69	-0.98	0.66	0.81	0.8	-0.65	0.29
Income Before Tax	-0.85	-0.04	-0.91	-0.88	-0.63	-0.5	-0.98	1.0	1.0	-0.95	1.0	-0.77	-0.98		-0.57	1.0	-0.55	-0.79	-0.75	0.61	-0.17
Total Other Income Expense Net	0.28	-0.66	0.53	0.42	0.75	0.72	0.7	-0.62	-0.6	0.78	-0.61	0.73	0.69	-0.57		-0.57	0.97	0.56	0.53	-0.68	0.59
Net Income	-0.84	-0.04	-0.91	-0.87	-0.64	-0.51	-0.98	1.0	1.0	-0.95	1.0	-0.78	-0.98	1.0	-0.57		-0.56	-0.79	-0.75	0.61	-0.17
Income Tax Expense	0.17	-0.71	0.59	0.31	0.77	0.75	0.67	-0.6	-0.57	0.75	-0.58	0.74	0.66	-0.55	0.97	-0.56		0.43	0.46	-0.66	0.53
Net Interest Income	0.87	0.04	0.56	0.91	0.39	0.27	0.81	-0.82	-0.82	0.76	-0.82	0.55	0.81	-0.79	0.56	-0.79	0.43		0.75	-0.33	0.11
Interest Income	0.79	0.04	0.68	0.74	0.67	0.63	0.8	-0.76	-0.75	0.76	-0.75	0.66	0.8	-0.75	0.53	-0.75	0.46	0.75		-0.25	0.26
Net Income From Continuing Ops	-0.3	0.35	-0.51	-0.44	-0.58	-0.53	-0.66	0.62	0.61	-0.72	0.62	-0.61	-0.65	0.61	-0.68	0.61	-0.66	-0.33	-0.25		-0.71
Reconciled Depreciation	-0.01	-0.38	0.14	0.12	0.61	0.67	0.31	-0.2	-0.18	0.38	-0.18	0.48	0.29	-0.17	0.59	-0.17	0.53	0.11	0.26	-0.71

Click cells to compare fundamentals

Icecure Medical Account Relationship Matchups

Icecure Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	(23.4K)	63K	127K	248K	323K	339.2K
Interest Expense	22.8K	31.7K	171K	239K	215.1K	120.2K
Selling General Administrative	1.3M	1.8M	4.1M	5.9M	4.2M	2.4M
Selling And Marketing Expenses	1.0M	1.1M	1.9M	3.2M	4.4M	4.7M
Total Revenue	1.7M	4.1M	4.1M	3.1M	3.2M	2.1M
Gross Profit	576.4K	2.7M	2.2M	1.4M	1.3M	957.4K
Other Operating Expenses	6.3M	8.4M	13.9M	19.8M	18.8M	19.7M
Operating Income	(4.6M)	(4.4M)	(9.7M)	(16.7M)	(15.6M)	(14.8M)
Ebit	(4.6M)	(4.1M)	(9.7M)	(16.7M)	(15.6M)	(14.8M)
Research Development	2.8M	4.1M	5.9M	9.1M	8.3M	8.7M
Ebitda	(4.6M)	(4.1M)	(9.6M)	(16.5M)	(15.3M)	(14.5M)
Cost Of Revenue	1.1M	1.4M	1.9M	1.6M	1.9M	1.1M
Total Operating Expenses	5.2M	7.0M	11.9M	18.2M	16.9M	17.7M
Income Before Tax	(4.8M)	(4.7M)	(9.9M)	(17.0M)	(14.7M)	(13.9M)
Total Other Income Expense Net	(165.2K)	412K	(171K)	(239K)	924K	970.2K
Net Income	(4.8M)	(4.8M)	(10.1M)	(17.2M)	(14.7M)	(13.9M)
Income Tax Expense	(13.6K)	86.8K	171K	239K	155.1K	162.9K
Net Interest Income	(698K)	(880K)	(171K)	(239K)	924K	970.2K
Net Income From Continuing Ops	(16.5M)	(15.1M)	(9.9M)	(17.0M)	(14.7M)	(15.4M)
Reconciled Depreciation	538K	856K	127K	248K	323K	365.2K
Net Income Applicable To Common Shares	(16.5M)	(15.1M)	(9.9M)	(17.0M)	(15.3M)	(16.0M)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Icecure Medical is a strong investment it is important to analyze Icecure Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icecure Medical's future performance. For an informed investment choice regarding Icecure Stock, refer to the following important reports:

How To Invest In Icecure

Details

Is Icecure Stock a good investment?

Details

What is Icecure Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.

You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.29)

Revenue Per Share

0.071

Quarterly Revenue Growth

0.079

Return On Assets

(0.47)

Return On Equity

(0.94)

The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Icecure Historical Income Statement

About Icecure Income Statement Analysis

Icecure Medical Income Statement Chart

Total Revenue

Other Operating Expenses

Icecure Medical income statement Correlations

Icecure Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Icecure Medical income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Net Income	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit

Total Operating Expenses	- 0.99	Ebitda
Total Operating Expenses	- 0.99	Ebit
Total Operating Expenses	- 0.99	Operating Income
Operating Income	- 0.99	Other Operating Expenses
Net Income	- 0.98	Total Operating Expenses
Income Before Tax	- 0.98	Total Operating Expenses